Ramjanee, S., Robertson, J., Franke-Fayard, B., Sinha, R., Waters, A., Janse, C., . . . Sinden, R. (2007). The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.
Dyfyniad Arddull ChicagoRamjanee, S., et al. The Use of Transgenic Plasmodium Berghei Expressing the Plasmodium Vivax Antigen P25 to Determine the Transmission-blocking Activity of Sera from Malaria Vaccine Trials. 2007.
Dyfyniad MLARamjanee, S., et al. The Use of Transgenic Plasmodium Berghei Expressing the Plasmodium Vivax Antigen P25 to Determine the Transmission-blocking Activity of Sera from Malaria Vaccine Trials. 2007.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.